Back to Search Start Over

Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis

Authors :
Eli Muchtar
Angela Dispenzieri
Brendan Wisniowski
Giovanni Palladini
Paolo Milani
Giampaolo Merlini
Stefan Schönland
Kaya Veelken
Ute Hegenbart
Susan M. Geyer
Shaji K. Kumar
Efstathios Kastritis
Meletios A. Dimopoulos
Michaela Liedtke
Ronald Witteles
Vaishali Sanchorawala
Raphael Szalat
Heather Landau
Erica Petrlik
Suzanne Lentzsch
Alexander Coltoff
Joan Bladé
Maria Teresa Cibeira
Oliver Cohen
Darren Foard
Ashutosh Wechalekar
Morie A. Gertz
Source :
Journal of Clinical Oncology. 41:1393-1403
Publication Year :
2023
Publisher :
American Society of Clinical Oncology (ASCO), 2023.

Abstract

PURPOSE Binary cardiac response assessment using cardiac biomarkers is prognostic in light chain amyloidosis. Previous studies suggested four-level cardiac responses using N-terminal prohormone of brain natiuretic peptide improves prognostic prediction. This study was designed to validate graded cardiac response criteria using N-terminal prohormone of brain natiuretic peptide/brain natiuretic peptide. PATIENTS AND METHODS This retrospective, multicenter study included patients with light chain amyloidosis who achieved at least a hematologic partial response (PR) and were evaluable for cardiac response. Four response criteria were tested on the basis of natriuretic peptide response depth: cardiac complete response (CarCR), cardiac very good partial response (CarVGPR), cardiac PR (CarPR), and cardiac no response (CarNR). Response was classified as best response and at fixed time points (6, 12, and 24 months from therapy initiation). The study primary outcome was overall survival. RESULTS 651 patients were included. Best CarCR, CarVGPR, CarPR, and CarNR were achieved in 16%, 26.4%, 22.9%, and 34.7% of patients, respectively. Patients in cardiac stage II were more likely to achieve CarCR than patients in cardiac stage IIIA and IIIB (22% v 13.5% v 3.2%; P < .001). A deeper cardiac response was associated with a longer survival (5-year overall survival 93%, 79%, 65%, and 33% for CarCR, CarVGPR, CarPR, and CarNR, respectively; P < .001). Fixed time-point analyses and time-varying covariates Cox regression analysis, to minimize survivorship bias, affirmed the independent survival advantage of deeper cardiac responses. Four-level response performed better than two-level response as early as 12 months from therapy initiation. CONCLUSION Graded cardiac response criteria allow better assessment of cardiac improvement compared with the traditional binary response system. The study re-emphasizes the importance of early diagnosis, which increases the likelihood of deep cardiac responses.

Subjects

Subjects :
Cancer Research
Oncology

Details

ISSN :
15277755 and 0732183X
Volume :
41
Database :
OpenAIRE
Journal :
Journal of Clinical Oncology
Accession number :
edsair.doi.dedup.....1a9615a68b80f2c9d259cbdf5bee03c5
Full Text :
https://doi.org/10.1200/jco.22.00643